Tetanus and diphtheria toxoids adsorbed (Decavac) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now
Tetanus vaccine, also known as tetanus toxoid (TT), is a toxoid vaccine used to prevent tetanus. During childhood, five doses are recommended, with a sixth given during adolescence.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

decavac | diphtheria and tetanus toxoids adsorbed | diphtheria and tetanus vaccine | diphtheria-tetanus toxoids adsorbed | diphtheria/tetanus vaccine | gc1107 | td-pur | td-rix | td vaccine | tedivax-adult | tetanus and diphtheria vaccine | tetanus and diptheria toxoids adsorbed | tetanus-diphtheria toxoid | tetanus-diphtheria vaccine

Organizations (38)

Research & Development (38)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (26)

Approved Indications (1)


 

Diphtheria-Tetanus Vaccine (approved 1955)

Experimental Indications - Clinical Trial Phases 1-4 (25)


 

Bacterial Infections (Phase 3)

Brain Neoplasms (Phase 1)

Breast Neoplasms (Phase 2)

Colonic Neoplasms (Phase 2)

Diarrhea (Phase 3)

Diffuse Intrinsic Pontine Glioma (Phase 2)

Diphtheria (Phase 4)

Diphtheria-Tetanus-acellular Pertussis Vaccines (Phase 3)

Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)

Glioblastoma (Phase 1)

Glioma (Phase 2)

Healthy Volunteers (Phase 3)

Hepatitis C (Phase 1)

HIV (Phase 4)

HIV Infections (Phase 1)

Infections (Phase 2)

Medulloblastoma (Phase 2)

Melanoma (Phase 1)

Multiple Sclerosis (Phase 2)

Pertussis Vaccine (Phase 3)

Pneumococcal Infections (Phase 1)

Substance-Related Disorders (Early Phase 1)

Tetanus (Phase 4)

Urinary Bladder Neoplasms (Phase 2)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial Organizations: 38

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue